期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (1)
Plants serve as an important source of medicinal compounds, and their use in various diseases dates back hundreds of years. One such plant-based compo......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (2)
Background: Bibliometric analysis can analyze development trends and predict research hotspots. We used these analyses to better understand the pregna......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (3)
Background: Premature ovarian failure (POF) refers to pathological amenorrhea before 40 years. Objective: To explore the regulatory effect of Rg1 on P......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (9)
Background: SREBP-1c/Insig/SCAP acts as a lipid de novo synthesis pathway, and its factors are highly expressed in the endoplasmic reticulum. At prese......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (8)
Objective: Cortex Mori Radicis (CMR) has been reported to possess antipyretic, anti-convulsant, anti-allergic, anti-inflammatory, and anti-diabetic ef......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (14)
Recent studies have shown that interleukin 1 beta monoclonal antibody improves the prognosis of patients with coronary artery disease independently of......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (5)
Background: Probiotics are a group of bacteria that play a critical role in intestinal microbiota homeostasis and may help adjunctively treat certain ......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (3)
Background: Diabetic nephropathy-related osteoporosis (DNOP) is the most common comorbid bone metabolic disorder associated with diabetes mellitus (DM......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (2)
Metabolic disorder affects normal homeostasis and can lead to the development of diseases. Diabetes mellitus is the most common metabolic disorder, an......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (10)
Diabetes mellitus is a metabolic disease caused by a combination of genetic and environmental factors. The importance of the inflammatory response occ......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (3)
Background: Multiple endocrine neoplasia type 2A (MEN 2A) is mainly caused by germline RET codon C634 mutation and is characterized by Medullary Thyro......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (6)
Background: Insulin Resistance (IR) is confirmed as a key feature of Nonalcoholic Fatty Liver Disease (NAFLD) in children and adolescents. Numerous st......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (10)
N6-methyladenosine (m6A) is a prevalent modification of RNA in eukaryotes, bacteria, and viruses. It is highly conserved and can affect the structure,......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022; 22 (5)
Aims: The aim of the study was to assess the effect of blocking TLR9 signaling on the proliferation of cervical cancer cells and its angiogenic proper......
期刊： ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021; 21 (6)
Background: College students may have a risk of fat-soluble vitamin deficiencies due to unhealthy dietary habits, especially for vitamin A and E. They......
